These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 23995368)

  • 1. Do established biomarkers such as B-type natriuretic peptide and troponin predict rejection?
    Hill DA; Drazner MH; de Lemos JA
    Curr Opin Organ Transplant; 2013 Oct; 18(5):581-8. PubMed ID: 23995368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide to diagnose acute rejection in pediatric cardiac transplant recipients.
    Dyer AK; Barnes AP; Fixler DE; Shah TK; Sutcliffe DL; Hashim I; Drazner MH; de Lemos JA
    Am Heart J; 2012 Apr; 163(4):595-600. PubMed ID: 22520525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro-brain natriuretic peptide as a potential non-invasive marker of cardiac transplantation rejection.
    Avello N; Molina BD; Llorente E; Bernardo MJ; Prieto B; Alvarez FV
    Ann Clin Biochem; 2007 Mar; 44(Pt 2):182-8. PubMed ID: 17362585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients.
    Battes LC; Caliskan K; Rizopoulos D; Constantinescu AA; Robertus JL; Akkerhuis M; Manintveld OC; Boersma E; Kardys I
    Transplantation; 2015 Mar; 99(3):580-5. PubMed ID: 25136844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in serial B-type natriuretic peptide level independently predict cardiac allograft rejection.
    Damodaran A; Dardas T; Wu AH; Dyke DB; Hummel SL; Cowger JA; Koelling TM
    J Heart Lung Transplant; 2012 Jul; 31(7):708-14. PubMed ID: 22502810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients.
    Kittleson MM; Skojec DV; Wittstein IS; Champion HC; Judge DP; Barouch LA; Halushka M; Hare JM; Kasper EK; Russell SD
    J Heart Lung Transplant; 2009 Jul; 28(7):704-9. PubMed ID: 19560699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of acute rejection following cardiac transplantation.
    McMinn JF; Lang NN; McPhadden A; Payne JR; Petrie MC; Gardner RS
    Biomark Med; 2014; 8(6):815-32. PubMed ID: 25224938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Association between serum NT-proBNP/hs-CRP and acute rejection after heart transplantation].
    Yin D; Huang J; Feng L; Feng GX; Hu SS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Feb; 37(2):145-8. PubMed ID: 19719993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B-type natriuretic peptide as a parameter for pulmonary hypertension in children. A systematic review.
    Ten Kate CA; Tibboel D; Kraemer US
    Eur J Pediatr; 2015 Oct; 174(10):1267-75. PubMed ID: 26298682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discoordinate modulation of natriuretic peptides during acute cardiac allograft rejection in humans.
    Masters RG; Davies RA; Veinot JP; Hendry PJ; Smith SJ; de Bold AJ
    Circulation; 1999 Jul; 100(3):287-91. PubMed ID: 10411854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarker for diagnosis of rejection after heart transplantation].
    Frick M; Antretter H; Pachinger O; Pölzl G
    Herz; 2010 Jan; 35(1):11-6. PubMed ID: 20140784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probrain natriuretic peptide and C-reactive protein as markers of acute rejection, allograft vasculopathy, and mortality in heart transplantation.
    Arora S; Gullestad L; Wergeland R; Simonsen S; Holm T; Hognestad A; Ueland T; Geiran O; Andreassen A
    Transplantation; 2007 May; 83(10):1308-15. PubMed ID: 17519779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of Acute Rejection by Global Longitudinal Strain and Cardiac Biomarkers in Heart-Transplanted Patients.
    Clemmensen TS; Firooznia N; Olawi FM; Løgstrup BB; Poulsen SH; Eiskjær H
    Front Immunol; 2022; 13():841849. PubMed ID: 35401567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochemistry of B-type natriuretic peptide--where are we now?
    Mair J
    Clin Chem Lab Med; 2008; 46(11):1507-14. PubMed ID: 18842106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.
    Hammerer-Lercher A; Mair J; Antretter H; Ruttmann E; Poelzl G; Laufer G; Puschendorf B; Hangler H
    J Heart Lung Transplant; 2005 Sep; 24(9):1444. PubMed ID: 16143273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of plasma biomarkers in acute heart failure. Serial changes and independent prognostic value of NT-proBNP and cardiac troponin-T.
    Metra M; Nodari S; Parrinello G; Specchia C; Brentana L; Rocca P; Fracassi F; Bordonali T; Milani P; Danesi R; Verzura G; Chiari E; Dei Cas L
    Eur J Heart Fail; 2007 Aug; 9(8):776-86. PubMed ID: 17573240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function.
    Bader FM; Rogers RK; Kfoury AG; Gilbert EM; Horne BD; Stehlik J; Renlund DG
    Congest Heart Fail; 2009; 15(2):63-7. PubMed ID: 19379451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of troponin assays for exclusion of acute cellular rejection after heart transplantation: A systematic review.
    Fitzsimons S; Evans J; Parameshwar J; Pettit SJ
    J Heart Lung Transplant; 2018 May; 37(5):631-638. PubMed ID: 29426716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of B-Type Natriuretic Peptide and N-Terminal Prohormone BNP as Predictors of Cardiovascular Morbidity and Mortality in Patients With a Recent Coronary Event and Type 2 Diabetes Mellitus.
    Wolsk E; Claggett B; Pfeffer MA; Diaz R; Dickstein K; Gerstein HC; Lawson FC; Lewis EF; Maggioni AP; McMurray JJV; Probstfield JL; Riddle MC; Solomon SD; Tardif JC; Køber L
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28554908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.